Atlas Trials

Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"

Clinical trial NCT01935466 · COMPLETED

Trial details

NCT number
NCT01935466
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2013-07-01
Primary completion
2021-10-01
Enrollment
6107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.